Olmesartan Medoxomil/Amlodipine Ascend (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil/Amlodipine Ascend, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults, often when single‑agent therapy does not provide adequate control. GNH USA supplies Olmesartan Medoxomil/Amlodipine Ascend as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomil/Amlodipine Ascend as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxomil/amlodipine is indicated for the management of hypertension, a condition characterized by elevated arterial pressure.

- Hypertension: provides additive blood pressure reduction by combining an angiotensin II receptor blocker with a calcium‑channel blocker. - High cardiovascular risk patients: helps achieve target blood pressure when monotherapy is insufficient. - Elderly patients with hypertension: offers once‑daily oral control with a favorable tolerability profile.

Adverse reactions may occur with any antihypertensive regimen and should be monitored during therapy.

Common Side Effects: - Dizziness or light‑headedness - Peripheral edema - Headache - Flushing - Fatigue - Nasal congestion

Serious or Rare Side Effects: - Angio‑edema involving the face, lips or tongue - Severe hypotension - Hepatic enzyme elevation - Acute kidney injury - Heart block or severe bradycardia - Allergic skin reactions such as Stevens‑Johnson syndrome

Before initiating therapy, clinicians should evaluate patient history and monitor relevant parameters.

- Renal impairment: adjust dose or monitor renal function regularly. - Hepatic disease: use with caution and observe liver enzymes. - Electrolyte disturbances: check potassium and sodium levels. - Concomitant diuretics: monitor for excessive blood pressure fall. - Pregnancy: contraindicated in the second and third trimesters. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Olmesartan medoxomil/amlodipine may interact with several drug classes; careful review of the medication list is essential.

Major Interactions (Avoid): - Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, other ARBs): risk of hyperkalaemia and renal dysfunction. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase amlodipine exposure.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect and affect renal function. - Potassium‑sparing diuretics or supplements: monitor serum potassium. - Lithium: may increase lithium levels, requiring serum monitoring. - Simvastatin: amlodipine can raise statin concentrations, increasing myopathy risk. - Alcohol: may enhance hypotensive effects.